Due to the interconnections between SerpinB3, HIF-2α-mediated regulation of lipid metabolism and NAFLD/NASH progression, we proposed in a recent study that SerpinB3, which is mainly expressed and released by stressed/injured hepatocytes, may represent an additional novel hepatokine [13]. Here, EPAS1 is linked to metabolic dysfunction-associated steatotic liver disease.